Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
One Innovation Labs LLC manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 2 pending office actions. These actions are distributed among 2 distinct examiners, indicating that the company's active applications are being reviewed independently by different staff members. This distribution suggests that the company is pursuing multiple distinct technical improvements within its field.
The portfolio's active cases are spread across 2 distinct art units. RICCI, CRAIG D is identified as the busiest examiner, currently overseeing 1 busiest examiner pending office action. Given the total of 2 pending office actions, the 1 action assigned to RICCI, CRAIG D represents a portion of the company's current prosecution activity. This distribution across 2 examiners and 2 art units suggests a technical review process for the company's pending matters. Practitioners must coordinate responses across 2 different art units, each potentially having its own examination standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
| KIM, DANIELLE A | 1 | 37.1% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18433084 | PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION | KIM, DANIELLE A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18595072 | LIPOSOME VITAMIN C PREPARATION | RICCI, CRAIG D | — |
| 18433084 | PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18595072 | LIPOSOME VITAMIN C PREPARATION | RICCI, CRAIG D | 1611 | §103 | Final Rejection | — | Pending | Mar 04, 2024 |
| 18433084 | PHYTOCANNABINOID FORMULATIONS AND METHODS FOR EXTRACTION | KIM, DANIELLE A | 1613 | §103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial